Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 389

1.

Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.

Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Davis MD, Ferris FL 3rd; Age-Related Eye Disease Study Research Group.

JAMA Ophthalmol. 2014 Mar;132(3):272-7. doi: 10.1001/jamaophthalmol.2013.6636.

PMID:
24385141
2.

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

Age-Related Eye Disease Study Research Group.

Arch Ophthalmol. 2001 Oct;119(10):1417-36. Erratum in: Arch Ophthalmol. 2008 Sep;126(9):1251.

3.

Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.

Age-Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, Clemons TE, Sangiovanni JP, Danis RP, Ferris FL 3rd, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Chandra SR, Blodi BA, Domalpally A, Friberg T, Wong WT, Rosenfeld PJ, Agrón E, Toth CA, Bernstein PS, Sperduto RD.

JAMA Ophthalmol. 2014 Feb;132(2):142-9. doi: 10.1001/jamaophthalmol.2013.7376.

4.

Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28.

Cukras C, Agrón E, Klein ML, Ferris FL 3rd, Chew EY, Gensler G, Wong WT; Age-Related Eye Disease Study Research Group.

Ophthalmology. 2010 Mar;117(3):489-99. doi: 10.1016/j.ophtha.2009.12.002. Epub 2010 Jan 15.

5.

Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.

Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Kurinij N, Davis MD; Age-Related Eye Disease Study Research Group.

Ophthalmology. 2013 Aug;120(8):1604-11.e4. doi: 10.1016/j.ophtha.2013.01.021. Epub 2013 Apr 10.

6.

Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.

Silva R, Cachulo ML, Fonseca P, Bernardes R, Nunes S, Vilhena N, Faria de Abreu JR.

Ophthalmologica. 2011;226(3):110-8. doi: 10.1159/000329473. Epub 2011 Aug 3.

PMID:
21822000
7.

Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.

Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd; Age-Related Eye Disease Study Research Group.

Ophthalmology. 2005 Apr;112(4):533-9.

8.

Risk factors for conversion to neovascular age-related macular degeneration based on longitudinal morphologic and visual acuity data.

Friberg TR, Bilonick RA, Brennen PM.

Ophthalmology. 2012 Jul;119(7):1432-7. doi: 10.1016/j.ophtha.2012.02.048. Epub 2012 May 1.

PMID:
22551740
9.

Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

Age-Related Eye Disease Study 2 Research Group.

JAMA. 2013 May 15;309(19):2005-15. doi: 10.1001/jama.2013.4997. Erratum in: JAMA. 2013 Jul 10;310(2):208.

PMID:
23644932
10.

Optical coherence tomography-based measurement of drusen load predicts development of advanced age-related macular degeneration.

Nathoo NA, Or C, Young M, Chui L, Fallah N, Kirker AW, Albiani DA, Merkur AB, Forooghian F.

Am J Ophthalmol. 2014 Oct;158(4):757-761.e1. doi: 10.1016/j.ajo.2014.06.021. Epub 2014 Jun 28.

PMID:
24983793
11.

Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration.

Wu Z, Ayton LN, Luu CD, Guymer RH.

JAMA Ophthalmol. 2015 Apr;133(4):442-8. doi: 10.1001/jamaophthalmol.2014.5963.

PMID:
25632841
12.

Risk of age-related macular degeneration 3 years after cataract surgery: paired eye comparisons.

Wang JJ, Fong CS, Rochtchina E, Cugati S, de Loryn T, Kaushik S, Tan JS, Arnold J, Smith W, Mitchell P.

Ophthalmology. 2012 Nov;119(11):2298-303. doi: 10.1016/j.ophtha.2012.07.003. Epub 2012 Sep 5.

PMID:
22959104
13.

Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group.

Writing Committee for the OPTOS PEripheral RetinA (OPERA) study (Ancillary Study of Age-Related Eye Disease Study 2), Domalpally A, Clemons TE, Danis RP, Sadda SR, Cukras CA, Toth CA, Friberg TR, Chew EY.

Ophthalmology. 2017 Apr;124(4):479-487. doi: 10.1016/j.ophtha.2016.12.004. Epub 2017 Jan 12.

PMID:
28089680
14.

The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).

AREDS2 Research Group, Chew EY, Clemons T, SanGiovanni JP, Danis R, Domalpally A, McBee W, Sperduto R, Ferris FL.

Ophthalmology. 2012 Nov;119(11):2282-9. doi: 10.1016/j.ophtha.2012.05.027. Epub 2012 Jul 26.

15.

The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.

Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Cukras C, Ferris FL 3rd, Chew EY; Age-Related Eye Disease Study 2 Research Group.

Ophthalmology. 2015 Dec;122(12):2490-6. doi: 10.1016/j.ophtha.2015.08.028. Epub 2015 Oct 4.

16.

Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration.

Sunness JS, Gonzalez-Baron J, Applegate CA, Bressler NM, Tian Y, Hawkins B, Barron Y, Bergman A.

Ophthalmology. 1999 Sep;106(9):1768-79.

PMID:
10485549
17.

Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10.

Vitale S, Clemons TE, Agrón E, Ferris FL 3rd, Domalpally A, Danis RP, Chew EY; Age-Related Eye Disease Study 2 (AREDS2) Research Group.

JAMA Ophthalmol. 2016 Sep 1;134(9):1041-7. doi: 10.1001/jamaophthalmol.2016.2383.

PMID:
27442263
18.

Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration.

Wu Z, Luu CD, Ayton LN, Goh JK, Lucci LM, Hubbard WC, Hageman JL, Hageman GS, Guymer RH.

Ophthalmology. 2014 Dec;121(12):2415-22. doi: 10.1016/j.ophtha.2014.06.034. Epub 2014 Aug 8.

PMID:
25109931
19.

Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study.

Souied EH, Delcourt C, Querques G, Bassols A, Merle B, Zourdani A, Smith T, Benlian P; Nutritional AMD Treatment 2 Study Group.

Ophthalmology. 2013 Aug;120(8):1619-31. doi: 10.1016/j.ophtha.2013.01.005. Epub 2013 Feb 8.

PMID:
23395546
20.

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9.

Age-Related Eye Disease Study Research Group.

Arch Ophthalmol. 2001 Oct;119(10):1439-52. Erratum in: Arch Ophthalmol. 2008 Sep;126(9):1251.

Supplemental Content

Support Center